SCHEMBL17561922

SCHEMBL17561922

CCCNc1ncc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1-c1cccnc1

nearest known ligand 0.82

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.82
▸ KCNH2 Q12809 2/20 0.68
▸ OPRM1 P35372 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17561927 0.95 ABL1 (0.85) ABL1KCNH2OPRM1
SCHEMBL16860176 0.92 ABL1 (0.90) ABL1KCNH2OPRM1
SCHEMBL16860234 0.90 ABL1 (1.00) ABL1KCNH2OPRM1
SCHEMBL17561926 0.88 ABL1 (0.68) ABL1KCNH2
SCHEMBL17561929 0.86 ABL1 (0.85) ABL1KCNH2
SCHEMBL16714121 0.84 ABL1 (1.00) ABL1KCNH2OPRM1
SCHEMBL17561928 0.83 ABL1 (0.71) ABL1KCNH2
SCHEMBL16864701 0.83 ABL1 (0.90) ABL1KCNH2
SCHEMBL17561924 0.82 ABL1 (0.87) ABL1KCNH2OPRM1
SCHEMBL16860423 0.81 ABL1 (1.00) ABL1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278981-B2 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 NOVARTIS AG (CH) 2016-03-08 — — US disclosed
Send feedback